Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE, a global leader in radioisotope production and radiopharmaceutical ...

South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global licensing agreement and strategic equity investment (SI) partnership to advance 1ST-104, a ...

To further enhance Taiwan’s role in global clinical research and innovative drug development, accelerate the advancement of cutting-edge medical technologies, and improve patient access to innovative ...